Avoid common mistakes on your manuscript.
Correction to: Clin Transl Oncol https://doi.org/10.1007/s12094-017-1783-2
The original article shows two mistakes, which are listed here:
-
1.
In paragraph 6 of the section “Second-line therapy: cabazitaxel and second-line hormone therapy” there was a mistake in line 6; instead of 0.65, it should have been written 0.74:
Overall survival was longer in the abiraterone group (14.8 months vs. 10.9 months; hazard ratio, 0.74; p < 0.001).
-
2.
In the original version of this article two algorithms were referenced in section “Methodology”, but were not included in the article. The missing algorithms are listed here:
Algorithm 1: Castration resistant disease
Algorithm 2: Hormonosensitive disease
Author information
Authors and Affiliations
Corresponding author
Additional information
The original article can be found online at https://doi.org/10.1007/s12094-017-1783-2.
Rights and permissions
About this article
Cite this article
Cassinello, J., Arranz, J.Á., Piulats, J.M. et al. Correction to: SEOM clinical guidelines for the treatment of metastatic prostate cancer (2017). Clin Transl Oncol 20, 110–111 (2018). https://doi.org/10.1007/s12094-017-1823-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-017-1823-y